Stephanie Yao
Keine laufenden Positionen mehr
Karriereverlauf von Stephanie Yao
Ehemalige bekannte Positionen von Stephanie Yao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KRONOS BIO, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| LENZ THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Investor Relations Contact | - | - |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Investor Relations Contact | 3 |
| Public Communications Contact | 2 |
Sektoral
| Health Technology | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| KRONOS BIO, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Graphite Bio, Inc.
 Graphite Bio, Inc. BiotechnologyHealth Technology Graphite Bio, Inc. is a clinical-stage gene editing company. It engages in the business of developing therapies that harness targeted gene integration to treat or cure serious diseases. The company was founded by Matthew Porteus and Maria Grazia Roncarolo on June 1, 2017 and is headquartered in South San Francisco, CA. | Health Technology |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Global Blood Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders. It also provides oral medicines for sickle cell diseases. The company was founded by Matthew P. Jacobson, Andrej Sali, Jack Taunton, Charles J. Homcy, Craig D. Muir, and David R. Phillips in February 2011 and is headquartered in South San Francisco, CA. | Health Technology |
- Börse
- Insiders
- Stephanie Yao
- Erfahrung
